Results 61 to 70 of about 3,621 (185)

Effect of triiodothyronine (T3) augmentation of acute milnacipran administration on monoamine levels: an in vivo microdialysis study in rats

Neuropsychiatric Disease and Treatment, 2012
Yuji Kitaichi, Takeshi Inoue, Shin Nakagawa, Shuken Boku, Akiko Kato, Ichiro Kusumi, Tsukasa KoyamaDepartment of Psychiatry, Hokkaido University Graduate School of Medicine, Sapporo, JapanBackground: Up to 30% of depressed patients are partially or ...
Kitaichi Y, Inoue T, Nakagawa S, Boku S, Kato A, Kusumi I, Koyama T   +6 more
doaj  

Comprehensive Characterization of Antidepressant Pharmacogenetics: A Systematic Review of Studies in Major Depressive Disorder

Clinical and Translational Science, Volume 18, Issue 6, June 2025.
ABSTRACT Pharmacogenetics is a promising strategy to facilitate individualized care for patients with Major Depressive Disorder (MDD). Research is ongoing to identify the optimal genetic markers for predicting outcomes to antidepressant therapies. The primary aim of this systematic review was to summarize antidepressant pharmacogenetic studies to ...
Caroline W. Grant, Karina Delaney, Linsey E. Jackson, Justin Bobo, Leslie C. Hassett, Liewei Wang, Richard M. Weinshilboum, Paul E. Croarkin, Melanie T. Gentry, Ann M. Moyer, Arjun P. Athreya   +10 more
wiley   +1 more source

Usefulness of milnacipran in treating phantom limb pain

Neuropsychiatric Disease and Treatment, 2012
Yasuhide Nagoshi,1 Akira Watanabe,1 Saiko Inoue,1 Tomoki Kuroda,2 Mitsuo Nakamura,3 Yoshitake Matsumoto,4 Kenji Fukui31Department of Psychiatry (Psychosomatic Medicine), Kyoto First Red Cross Hospital, Kyoto, Japan; 2Gojouyama Hospital, Nara, Japan ...
Matsumoto Y, Nakamura M, Kuroda T, Inoue S, Watanabe A, Nagoshi Y, Fukui K   +6 more
doaj  

Role and rationale for the use of milnacipran in the management of fibromyalgia

Neuropsychiatric Disease and Treatment, 2010
Jay D Kranzler, R Michael GendreauCypress Bioscence, San Diego, CA, USAAbstract: Fibromyalgia (FM) is a complex syndrome characterized by chronic widespread musculoskeletal pain which is often accompanied by multiple other symptoms, including fatigue ...
Jay D Kranzler, R Michael Gendreau
doaj  

Development of a new, rapid and sensitive HPTLC method for estimation of Milnacipran in bulk, formulation and compatibility study

, 2017
A simple, sensitive and rapid high performance thin layer chromatographic (HPTLC) method has been developed and validated for quantitative determination of Milnacipran Hydrochloride (MIL) in bulk and formulations.
Gautam Singhvi, V. Shukla, R. Ukawala, Gautham Gampa, R. Saha   +4 more
semanticscholar   +1 more source

Double-blind, comparative study of milnacipran and paroxetine in Japanese patients with major depression

Neuropsychiatric Disease and Treatment, 2013
Kunitoshi Kamijima,1 Shinji Hashimoto,2 Eiichi Nagayoshi,2 Tsukasa Koyama3 1International University of Health and Welfare, Tochigi, 2Asahi-kasei Pharma Corporation, Tokyo, 3Ohyachi Hospital, Sapporo, Japan Background and methods: A double-blind ...
Kamijima K, Hashimoto S, Nagayoshi E, Koyama T   +3 more
doaj  

Improvement of the noradrenergic symptom cluster following treatment with milnacipran

Neuropsychiatric Disease and Treatment, 2011
Siegfried Kasper, Diana Meshkat, Alexandra KutzelniggDepartment of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, AustriaAbstract: Depression has a major impact on social functioning.
Kasper S, Meshkat D, Kutzelnigg A
doaj  

Utilization of ion-pair complexation reaction for the spectrophotometric determination of milnacipran HCl as anti-depression drug in pharmaceutical formulations

Bulletin of Faculty of Science, Zagazig University, 2023
A. Gouda, R. Elsheikh, E. Fawzy, Basma Mohamed   +3 more
semanticscholar   +1 more source

Influence of the selective antagonist of the NR2B subunit of the NMDA receptor, traxoprodil, on the antidepressant-like activity of desipramine, paroxetine, milnacipran, and bupropion in mice

Journal of neural transmission, 2016
Pre-clinical and clinical studies indicated that a blockade of the NMDA receptor complex creates new opportunities for the treatment of affective disorders, including depression. The aim of the present study was to assess the influence of traxoprodil (10 
Weronika Stasiuk, A. Szopa, A. Serefko, E. Wyska, K. Świąder, Jarosław Dudka, P. Wlaź, E. Poleszak   +7 more
semanticscholar   +1 more source

Newer treatments for fibromyalgia syndrome

Therapeutics and Clinical Risk Management, 2008
Richard E Harris, Daniel J ClauwDepartment of Anesthesiology, The University of Michigan, Ann Arbor, MI, USAAbstract: Fibromyalgia syndrome is a common chronic pain disorder of unknown etiology.
Richard E Harris, Daniel J Clauw
doaj